Chevy Chase Trust
GSK icon

Chevy Chase Trust’s GSK GSK Stock Holding History

Chevy Chase Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,119
Closed -$66K – 776
2019
Q4 		$66K Buy
+1,119
New +$62.2K ﹤0.01% 778
2018
Q4 		– Sell
-5,539
Closed -$278K – 733
2018
Q3 		$278K Buy
5,539
+956
+21% +$48.6K ﹤0.01% 620
2018
Q2 		$231K Hold
4,583
– – ﹤0.01% 640
2018
Q1 		$224K Buy
+4,583
New +$213K ﹤0.01% 636
2017
Q2 		– Sell
-3,811
Closed -$201K – 661
2017
Q1 		$201K Sell
3,811
-375
-9% -$19K ﹤0.01% 635
2016
Q4 		$201K Sell
4,186
-736
-15% -$36.4K ﹤0.01% 648
2016
Q3 		$265K Sell
4,922
-109
-2% -$5.98K ﹤0.01% 604
2016
Q2 		$273K Sell
5,031
-1,307
-21% -$68.9K ﹤0.01% 605
2016
Q1 		$321K Buy
6,338
+587
+10% +$29.2K ﹤0.01% 599
2015
Q4 		$290K Hold
5,751
– – ﹤0.01% 613
2015
Q3 		$276K Sell
5,751
-1,571
-21% -$81.8K ﹤0.01% 612
2015
Q2 		$381K Sell
7,322
-640
-8% -$36K ﹤0.01% 596
2015
Q1 		$459K Sell
7,962
-299
-4% -$17.1K ﹤0.01% 599
2014
Q4 		$442K Sell
8,261
-4,122
-33% -$231K ﹤0.01% 608
2014
Q3 		$712K Sell
12,383
-2,342
-16% -$144K ﹤0.01% 589
2014
Q2 		$984K Buy
14,725
+2,222
+18% +$150K 0.01% 572
2014
Q1 		$835K Buy
12,503
+3,373
+37% +$228K 0.01% 577
2013
Q4 		$609K Buy
9,130
+2,387
+35% +$155K ﹤0.01% 584
2013
Q3 		$423K Sell
6,743
-160
-2% -$10.3K ﹤0.01% 597
2013
Q2 		$431K Buy
+6,903
New +$438K ﹤0.01% 597

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Chevy Chase Trust's GSK Position: Q1 2020 in Review

Chevy Chase Trust sold out of GSK (GSK) in Q1 2020, closing a stake of 1,119 shares — an estimated $66K sold.

Chevy Chase Trust first reported a position in GSK in Q2 2013 and held it in 20 quarters. The position peaked at $984K in Q2 2014. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • Chevy Chase Trust reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • Chevy Chase Trust sold 1,119 GSK shares in Q1 2020, an estimated $66K.
  • Chevy Chase Trust first reported a position in GSK in Q2 2013 and held it in 20 quarters.
  • Chevy Chase Trust's GSK position peaked at $984K in Q2 2014.
  • 817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Chevy Chase Trust's 13F filing for Q1 2020, filed 13 May 2020.